# ImmunoMolecular Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/immunomolecular-therapeutics

- Industry: Biotechnology
- Headquarters: Aurora, US
- Website: www.imtherapeutics.com
- Total disclosed funding: $10M
- Latest round: Series A (Oct 9, 2019)
- Investors on record: 3

## About

Based in Colorado, US, ImmunoMolecular Therapeutics, Inc. operates as a clinical-stage company that develops oral drug therapies for autoimmune disease against human leukocyte antigen (HLA) variants.

## Funding rounds

- Series A, Oct 9, 2019, $10M — 5Y Capital, JDRF T1D Fund, Colorado University Healthcare Innovation Fund

## Investors

- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series A
- JDRF T1D Fund (https://capitalatlas.ai/funds/jdrf-t1d-fund) — Series A
- Colorado University Healthcare Innovation Fund — Series A